Is BCDA up or down today?
BCDA is down 7.02% today, last at 0.8610. This stock moved -7.02% versus the prior close.
BCDA · BCDA
BCDA (BCDA) is trading at 0.8610, down 7.02% on the session. BCDA sits at the 11% mark of its 52-week range, carries a 14-day RSI of 38, and trades below its 50-day average. Over the past month it is down 15.59%.
Leading the coverage: “BioCardia Inc (6JU0.MU) stock price, news, quote and history - Yahoo Finance Australia” (Google News Company, 3d ago). BCDA is -4.33% since story.
BCDA trades on a trailing P/E of 29.4 and is running 14.68% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
BCDA is down 7.02% today, last at 0.8610. This stock moved -7.02% versus the prior close.
Leading the coverage: “BioCardia Inc (6JU0.MU) stock price, news, quote and history - Yahoo Finance Australia” (Google News Company, 3d ago). BCDA is -4.33% since story. Dominant story: BioCardia Inc (6JU0.MU) stock price, news, quote and history - Yahoo Finance Australia (1 source, neutral) RSI is 38 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Oct 2026 (127 days) · Drag or scroll left for earlier dates
BioCardia Inc (6JU0.MU) stock price, news, quote and history - Yahoo Finance Australia
BCDA Q2 2026 Earnings: Narrower-Than-Expected Loss Draws Focus to Cash Discipline - Debt Analysis Report - https://www.siam.in/
At $0.95 per share, BioCardia (BCDA) CEO buys 500 shares across two purchases. - Stock Titan
BioCardia president and CEO Peter Altman buys $475 in BCDA shares - Investing.com
BioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this Quarter